+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 21Years - 45Years
All Genders
ID07815691

Exploring Sex Differences in THC Effects Using Oral Dronabinol in Adults with Cannabis Use Disorder

Led by Medical University of South Carolina · Updated on 2026-10-05

78

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying how cannabis affects men and women differently, focusing on people who regularly use cannabis. This Phase 2 trial involves participants aged 21 to 45 who meet criteria for cannabis use disorder and use cannabis at least four days a week. The study aims to explore sex differences in the effects of THC, the active chemical in cannabis, and includes genetic and brain imaging assessments. Participants will attend three in-person visits. The first visit screens for eligibility. The next two visits, at least two days apart, last about seven hours each. During these, participants receive either oral dronabinol capsules 40 mg of THC or placebo capsules in a randomized, double-blind crossover design. Each visit includes completing questionnaires and a one-hour brain scan. One visit also involves a blood draw for genetic testing. Throughout the study, researchers will measure brain chemicals like glutamate in specific brain regions two hours after dosing. Participants will complete drug effect questionnaires up to seven hours post-dose to assess their experience. The study will monitor sex differences in genetics and brain response to THC. The total participation involves multiple assessments and careful monitoring at each visit to understand THCs effects across sexes.

CONDITIONS

Brief Title

Endocannabinoids in Reward

Research Team

E

Erin Martin, Ph.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here